Prognostic role of % changes in longest tumor diameter (LTD) in localized high-risk soft tissue sarcoma (STS) treated with neoadjuvant chemotherapy in a randomized clinical trial.

Authors

Silvia Stacchiotti

Silvia Stacchiotti

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Silvia Stacchiotti , Carlo Morosi , Luca Braglia , Emanuela Palmerini , Vittorio Quagliuolo , Javier Martin Broto , Antonio Lopez-Pousa , Giovanni Grignani , Antonella Brunello , Jean-Yves Blay , Oscar Tendero , Robert Diaz Beveridge , Iwona Lugowska , Valeria Fontana , Emanuela Marchesi , Elena Palassini , Paolo Bruzzi , Franco Domenico Merlo , Paolo Giovanni Casali , Alessandro Gronchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT01710176

Citation

J Clin Oncol 38: 2020 (suppl; abstr 11558)

DOI

10.1200/JCO.2020.38.15_suppl.11558

Abstract #

11558

Poster Bd #

446

Abstract Disclosures